Pubdate: Fri, 18 Feb 2005
Source: Globe-Gazette (IA)
Copyright: 2005 Globe-Gazette
Contact: http://www.globegazette.com/sitepages/modules/editorltr.shtml
Website: http://www.globegazette.com/
Details: http://www.mapinc.org/media/1568
Author: Dan Gearino, Globe Des Moines Bureau
Bookmark: http://www.mapinc.org/meth.htm (Methamphetamine)

SENATE OKS CHECKS ON METH PRECURSOR DRUG

DES MOINES -- The Iowa Senate on Thursday unanimously approved restrictions 
on the sale of the cold remedy pseudoephedrine.

The measure sharply limits access to the ingredient which can be used to 
produce methamphetamine, but is not as restrictive as many lawmakers and 
anti-drug advocates believe is necessary.

"I think the resounding message coming out of the Senate is that we want to 
make sure these drugs, sold in places in Iowa, do not end up in meth labs," 
said Senate Democratic Leader Mike Gronstal of Council Bluffs.

The Senate passage sets up a battle with the Iowa House, where Speaker 
Christopher Rants, R-Sioux City, says he opposes the bill and may not allow 
it to be debated.

At the same time, a House committee is working on a bill that will likely 
be more restrictive than the one from the Senate.

Under the Senate bill, any product containing more than 360 milligrams of 
pseudoephedrine would be classified as a Schedule V controlled substance, 
which means it could only be sold by pharmacists. Also, customers would be 
limited to two packages containing the drug in 24 hours and 6,000 
milligrams in 30 days, unless they have a prescription.

Products containing 360 milligrams or less, which includes many small 
packages of cold medicine, could be sold by regular retailers, but the 
items would have to be kept behind the counter in a locked cabinet.

People who purchase the drugs would be required to show photo 
identification and enter their name and address in a logbook.

Retailers who violate the rules would be subject to civil penalties, with 
escalating fines for multiple offenses and the possibility of being barred 
from selling the drug.

One reason for the unanimous vote was an amendment that removed some of the 
elements retailers found most cumbersome or difficult to enforce.

One of the changes was the removal of a penalty for retailers who sell the 
same customer more than the monthly limit, which retailers said would be 
nearly impossible to track without an electronic database.

Advocates for retailers are less enthused about the bill being written in 
the House Public Safety Committee. An early draft of the bill would 
classify nearly every product containing pseudoephedrine as a Schedule V 
controlled substance and would limit customers to 4,000 milligrams of the 
drug per month.
- ---
MAP posted-by: Beth